Effect of Low-Dose Heparinized Saline (LDHS) on Arterial Line Patency Patients with Severe COVID-19 Disease

Authors

  • Narisa Ajonsre Faculty of Medicine Siriraj Hospital, Mahidol University https://orcid.org/0009-0002-2727-3896
  • Akarin Nimmannit Faculty of Medicine Siriraj Hospital, Mahidol University
  • Auengporn Pituksung Faculty of Medicine Siriraj Hospital, Mahidol University
  • Wisansaya Kampukhiaw Faculty of Medicine Siriraj Hospital, Mahidol University
  • Patcharee Butsankot Faculty of Medicine Siriraj Hospital, Mahidol University
  • Mayura Vattanapongpisan Faculty of Medicine Siriraj Hospital, Mahidol University
  • Ranistha Ratanarat Faculty of Medicine Siriraj Hospital, Mahidol University

Keywords:

Arterial line, COVID-19, Critical care, Heparin

Abstract

        Introduction: In critically ill COVID-19 patients, arterial line (A-line) occlusion occurs more frequently than in general ICU patients when 0.9% NSS is used as a flushing solution. Objective: To evaluate the effectiveness of low-dose heparinized saline (LDHS), consisting of 2 units of heparin per 1 mL of 0.9% NSS, in maintaining arterial line (A-line) patency in critically ill COVID-19 patients. Methods: This randomized controlled trial included 61 critically ill COVID-19 patients, an experimental group (n=31) receiving LDHS and a control group (n=30) receiving NSS. Both solutions were administered under continuous pressure using a pressure bag inflated to 400 mmHg. Data collection tools included: 1) experimental instruments and 2) data recording forms. Data Analysis: The proportion of functional arterial lines and complication rates were compared between groups using Pearson’s chi-square test. Duration of line patency was analyzed using Kaplan–Meier survival analysis and the log-rank test. Results: LDHS and NSS demonstrated comparable effectiveness in preventing arterial line occlusion, with mean patency durations of 22.47 days and 26.36 days, respectively (p = .479). Conclusion: In critically ill COVID-19 patients, 0.9% NSS can be effectively used as an arterial line flushing solution when combined with a pressure bag inflated to 400 mmHg, thereby extending line patency without the need for heparin.

Downloads

Download data is not yet available.

References

Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559-1561. doi:10.1111/jth.14849.

Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-1026. doi:10.1111/jth.14810.

Everson M, Webber L, Penfold C, Shah S, Freshwater-Turner D. Finding a solution: Heparinised saline versus normal saline in the maintenance of invasive arterial lines in intensive care. J Intensive Care Soc. 2016;17(4):284-289. doi:10.1177/1751143716653763.

Zhong L, Wang HL, Xu B, et al. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis. Crit Care. 2017;21(1):5. doi:10.1186/s13054-016-1585-x.

Ziyaeifard M, Ferasat-Kish R, Azarfarin R, et al. Comparison of the effect of heparinized normal saline solution versus saline solutions in arterial and central venous catheters on complete blood count after cardiac surgery. Anesth Pain Med. 2022;12(4):e113345. doi:10.5812/aapm-113345.

Robertson-Malt S, Malt GN, Farquhar V, Greer W. Heparin versus normal saline for patency of arterial lines. Cochrane Database Syst Rev. 2014;2018(5):CD007364. doi:10.1002/14651858.CD007364.pub2.

Ishii Y, Mishima S, Aida K, Oda J. Comparison of normal saline and heparinized solutions for the maintenance of arterial catheter pressure waves: A randomized pilot study. Signa Vitae. 2021 Feb;17(1):51-5. doi:10.22514/sv.2020.16.0088.

Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-1098. doi:10.1007/s00134-020-06062-x.

Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(16):1815-1826. doi:10.1016/j.jacc.2020.08.041.

Maurer LR, Luckhurst CM, Hamidi A, et al. A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients. J Crit Care. 2020;60:253-259. doi:10.1016/j.jcrc.2020.08.025.

Hamad AA, Ahmed SK. Understanding the lower and upper limits of sample sizes in clinical research. Cureus. 2025;17(1):e76724. doi:10.7759/cureus.76724.

P. Hanrahan N, Letourneau L, Batty R. Nurse management of radial arterial lines: Quality & Safety. Am J Nurs Res. 2022;10(1):7-15. doi:10.12691/ajnr-10-1-2.

Atef Fathi Moosa Elkholy M, Faltas Marzouk S, Ahmed Elhaweet E. Nurses’ compliance with safety measures of arterial line. Egyptian Journal of Health Care. 2024;15(4):49-61. doi:10.21608/ejhc.2024.383810.

Downloads

Published

2025-08-20

How to Cite

1.
Ajonsre N, Nimmannit A, Pituksung A, Kampukhiaw W, Butsankot P, Vattanapongpisan M, Ratanarat R. Effect of Low-Dose Heparinized Saline (LDHS) on Arterial Line Patency Patients with Severe COVID-19 Disease. J Chulabhorn Royal Acad [internet]. 2025 Aug. 20 [cited 2026 Feb. 13];7(3):273-81. available from: https://he02.tci-thaijo.org/index.php/jcra/article/view/275508

Issue

Section

Research Articles